155 related articles for article (PubMed ID: 12071429)
1. Effects of rhIGF-I and insulin-induced hypoglycaemia on cardiovascular parameters recorded with telemetry in the conscious dog.
Ilbäck NG; Gunnarsson K; Stålhandske T
Pharmacol Toxicol; 2002 Feb; 90(2):73-81. PubMed ID: 12071429
[TBL] [Abstract][Full Text] [Related]
2. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
Kerr D; Tamborlane WV; Rife F; Sherwin RS
J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of xylazine recorded with telemetry in the dog.
Ilbäck NG; Stålhandske T
J Vet Med A Physiol Pathol Clin Med; 2003 Dec; 50(10):479-83. PubMed ID: 15157013
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemic and insulin response to a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) in healthy males.
Morgan JM; Saris SD; Capuzzi DM; Good WR; John VA; Guler HP; Seaman J; Piraino AJ
J Clin Pharmacol; 1993 Apr; 33(4):366-72. PubMed ID: 8473552
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy males.
Morgan JM; Piraino AJ; Saris SD; Capuzzi DM
Int J Clin Pharmacol Ther; 1994 May; 32(5):235-9. PubMed ID: 7921517
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR; Sleevi M; Allan G; Sommer A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
[TBL] [Abstract][Full Text] [Related]
8. A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (mAb Fab-SEA/E) using telemetric monitoring in conscious rabbits.
Ilbäck NG; Persson R; Gunnarsson K; Stålhandske T
J Pharmacol Toxicol Methods; 2002; 48(1):31-9. PubMed ID: 12750039
[TBL] [Abstract][Full Text] [Related]
9. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
[TBL] [Abstract][Full Text] [Related]
10. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
[TBL] [Abstract][Full Text] [Related]
11. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
Mauras N; Horber FF; Haymond MW
J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat.
Ilbäck NG; Siller M; Stålhandske T
Food Chem Toxicol; 2007 May; 45(5):834-42. PubMed ID: 17175084
[TBL] [Abstract][Full Text] [Related]
14. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.
Crowne EC; Samra JS; Cheetham T; Watts A; Holly JM; Dunger DB
Metabolism; 1998 Jan; 47(1):31-8. PubMed ID: 9440474
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
[TBL] [Abstract][Full Text] [Related]
17. Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults.
Bisi G; Podio V; Valetto MR; Broglio F; Bertuccio G; DEl Rio G; Boghen MF; Berti F; Muller EE; Ghigo E
Eur J Endocrinol; 1999 Apr; 140(4):322-7. PubMed ID: 10097251
[TBL] [Abstract][Full Text] [Related]
18. Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats.
Ilbäck NG; Siller M; Stålhandske T
Lab Anim; 2008 Apr; 42(2):149-60. PubMed ID: 18435873
[TBL] [Abstract][Full Text] [Related]
19. Telemetric monitoring of cardiovascular parameters in conscious spontaneously hypertensive rats.
Bazil MK; Krulan C; Webb RL
J Cardiovasc Pharmacol; 1993 Dec; 22(6):897-905. PubMed ID: 7509911
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
Takahara A; Dohmoto H; Yoshimoto R; Sugiyama A; Hashimoto K
Eur J Pharmacol; 2001 Feb; 413(1):101-8. PubMed ID: 11173068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
